Newscope Capital Corporation
Newscope Capital Corporation
CSE Index:
Currency:
Pharmather is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals. Pharmather was founded with a particular focus on repurposing psychedelic pharmaceuticals, such as ketamine and psilocybin, for FDA approval to treat disorders of the brain and nervous system.
Newscope Capital Corporation (PHRM)
SEDAR Information
Company Info
Address
82 Richmond Street East
Toronto, ON M5C 1P1
CanadaPhone
1-888-846-3171Email
info@pharmather.comWebsite
https://www.pharmather.comListing date
Friday, October 9, 2020Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
69,609,865Reserved for Issuance:
3,802,200Total equity shares, as if converted:
5,000,000Company Officers
Fabio Chianelli, Chief Executive Officer
Carmelo Marrelli, Chief Financial Officer
Andrew Todd, Corporate Secretary
News Releases
Bulletins
08/10/2020
2020-1011 – New Listing - Newscope Capital Corporation (PHRM)
Le 8 octobre/October 2020
The common shares of Newscope Capital Corporation have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
Advertisement
Publicité
Upcoming Events
Tech Tuesdays
Series
Investing in Psychedelics Series: Building Value Through IP
Wednesday, January 20, 2021 -1:00pm to 4:00pm
Health Tech Thursdays
Series
